Page last updated: 2024-09-04

carbapenems and cyslabdan

carbapenems has been researched along with cyslabdan in 1 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(cyslabdan)
Trials
(cyslabdan)
Recent Studies (post-2010) (cyslabdan)
7,3551475,277907

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumoto, A; Hanaki, H; Kim, YP; Omura, S; Shiomi, K; Tomoda, H1

Other Studies

1 other study(ies) available for carbapenems and cyslabdan

ArticleYear
Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    The Journal of antibiotics, 2008, Volume: 61, Issue:1

    Topics: Acetylcysteine; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Diterpenes; Drug Synergism; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptomyces

2008